Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.1050 (1.94%) ($7.1050 - $7.1050) on Mon. Aug. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.22% (three month average) | RSI | 44 | Latest Price | $7.1050(1.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -4.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) EDOC(43%) OIH(18%) XBI(36%) VIXM(26%) USO(19%) | Factors Impacting BCRX price | BCRX will decline at least -1.61% in a week (0% probabilities). XLRE(-42%) XLP(-39%) XLV(-29%) SPLV(-27%) EWG(-27%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -1.61% (StdDev 3.22%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.23(-117.31%) | Resistance Level | $7.26 | 5 Day Moving Average | $7.02(1.21%) | 10 Day Moving Average | $7.05(0.78%) | 20 Day Moving Average | $7.26(-2.13%) | To recent high | -19.8% | To recent low | 6% | Market Cap | $1.254b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |